SEKISUI Diagnostics
Chris Carter is a seasoned professional with extensive experience in technical operations and process development within the biotechnology and diagnostics sectors. Currently serving as a Technical Operations Scientist at Sekisui Diagnostics, LLC since November 2015, Chris is involved in the daily support of manufacturing operations. Prior to this role, Chris held positions as a Process Development Associate II at Abbott Diagnostics from May 2009 to October 2015, and as a Technical Support Specialist at Pfizer between February 2000 and April 2009. Early career experience includes work as a Fermentation Scientist at Delta Biotechnology in 1999 and another role as a Fermentation Scientist in the same year. Chris holds a Master’s degree in Industrial Biotechnology and a Bachelor’s degree in Applied Microbiology from Liverpool John Moores University, completed between 1995 and 1999.
This person is not in any offices
SEKISUI Diagnostics
4 followers
Headquartered in Burlington, MA, for 40 years SEKISUI Diagnostics has been committed to helping improve the lives of patients by providing innovative medical diagnostics to physicians and laboratories. We continue to invest in the areas of diabetes, infectious disease, coagulation, diagnostic enzymes and automated systems, and have a leading position as a provider of rapid tests in the US and high throughput coagulation systems in Japan. Our workforce spans six sites located in four countries. We are a sister company to SEKISUI Medical in Japan, making us a worldwide company with R&D and Manufacturing facilities on three continents. We develop, manufacture, and supply billions of tests each year to the global healthcare market through our commercial networks and partners. Our product lines include: • Clinical chemistry reagents • Coagulation reagents • Point-of-care rapid tests and immunoassay system • Enzymes and specialty biochemicals